Frontiers in Oncology | Hematologic Malignancies

Case Report

Published on 23 Sep 2021

Case Report: Ocular Manifestations and Treatments of Ciliary Body Involvement by Lymphoma

in Hematologic Malignancies

Yu Di
Junjie Ye
Ruoan Han
Mengda Li
Bilei Zhang

Frontiers in Oncology

doi 10.3389/fonc.2021.718759

3,201 views
4 citations

Original Research

Published on 22 Sep 2021

Bortezomib Inhibits Multiple Myeloma Cells by Transactivating ATF3 to Trigger miR-135a-5p- Dependent Apoptosis

in Hematologic Malignancies

Xiaolan Lai
Chuanqian Huang
Xuekun Nie
Qi Chen
Yirong Tang
Xianguo Fu
Ying Lin
Chengjun Nie
Xinyu Xu
Xiukang Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.720261

5,875 views
7 citations

Case Report

Published on 21 Sep 2021

Case Report: Multi-Omics Analysis and CAR-T Treatment of a Chronic Myeloid Leukemia Blast Crisis Case 5 Years After the Discontinuation of TKI

in Hematologic Malignancies

Ya-Ru Miao
Wen Liu
Zhaodong Zhong
Yong You
Yutong Tang
Weiming Li
Xiaojian Zhu
An-Yuan Guo

Frontiers in Oncology

doi 10.3389/fonc.2021.739871

5,192 views
9 citations

Original Research

Published on 21 Sep 2021

Inefficacy of Immunosuppressive Therapy for Severe Aplastic Anemia Progressing From Non-SAA: Improved Outcome After Allogeneic Hematopoietic Stem Cell Transplantation

in Hematologic Malignancies

Limin Liu
Xin Zhao
Miao Miao
Yanming Zhang
Wenjing Jiao
Meiqing Lei
Huifen Zhou
Qingyuan Wang
Yifeng Cai
Liyun Zhao

Frontiers in Oncology

doi 10.3389/fonc.2021.739561

4,941 views
4 citations

Original Research

Published on 20 Sep 2021

Somatic Mutations in Oncogenes Are in Chronic Myeloid Leukemia Acquired De Novo via Deregulated Base-Excision Repair and Alternative Non-Homologous End Joining

in Hematologic Malignancies

Nikola Curik
Vaclava Polivkova
Pavel Burda
Jitka Koblihova
Adam Laznicka
Tomas Kalina
Veronika Kanderova
Jana Brezinova
Sarka Ransdorfova
Dominika Karasova

Frontiers in Oncology

doi 10.3389/fonc.2021.744373

5,023 views
9 citations

Case Report

Published on 16 Sep 2021

Safety and Efficacy of Anti-CD19-Chimeric Antigen Receptor T Cell Combined With Programmed Cell Death 1 Inhibitor Therapy in a Patient With Refractory Post-Transplant Lymphoproliferative Disease: Case Report and Literature Review

in Hematologic Malignancies

Gang Feng
Qing Li
Haibo Zhu
Yanyu Jiang
Jijun Yuan
Yingxin Fu
Qi Deng

Frontiers in Oncology

doi 10.3389/fonc.2021.726134

5,567 views
15 citations

Case Report

Published on 16 Sep 2021

Salvage Therapy With Polatuzumab Vedotin, Bendamustine, and Rituximab Prior to Allogeneic Hematopoietic Transplantation in Patients With Aggressive Lymphomas Relapsing After Therapy With Chimeric Antigen Receptor T-Cells—Report on Two Cases

in Hematologic Malignancies

Kristin Gerhardt
Madlen Jentzsch
Thomas Georgi
Aleksandra Sretenović
Michael Cross
Enrica Bach
Astrid Monecke
Sabine Leiblein
Sandra Hoffmann
Milena Todorović

Frontiers in Oncology

doi 10.3389/fonc.2021.737645

7,442 views
6 citations

Editorial

Published on 15 Sep 2021

Editorial: Novel Treatment Strategies for Myeloproliferative Neoplasms

in Hematologic Malignancies

Ken-Hong Lim
Shinobu Matsuura
Bing Xu

Frontiers in Oncology

doi 10.3389/fonc.2021.762928

2,567 views

Case Report

Published on 13 Sep 2021

Comprehensive Clinicopathologic and Molecular Analysis of Mast Cell Leukemia With Associated Hematologic Neoplasm: A Report and In-Depth Study of 5 Cases

in Hematologic Malignancies

Philippa Li
Giulia Biancon
Timil Patel
Zenggang Pan
Shalin Kothari
Stephanie Halene
Thomas Prebet
Mina L. Xu

Frontiers in Oncology

doi 10.3389/fonc.2021.730503

3,793 views
3 citations

Original Research

Published on 13 Sep 2021

Four and a Half LIM Domains Protein 2 Mediates Bortezomib-Induced Osteogenic Differentiation of Mesenchymal Stem Cells in Multiple Myeloma Through p53 Signaling and β-Catenin Nuclear Enrichment

in Hematologic Malignancies

Zhenqing Xie
Yan Xu
Xiaojing Wei
Gang An
Mu Hao
Zhen Yu
Lugui Qiu

Frontiers in Oncology

doi 10.3389/fonc.2021.729799

4,224 views
3 citations

Original Research

Published on 13 Sep 2021

High EVI1 Expression Predicts Adverse Outcomes in Children With De Novo Acute Myeloid Leukemia

in Hematologic Malignancies

Yongzhi Zheng
Yan Huang
Shaohua Le
Hao Zheng
Xueling Hua
Zaisheng Chen
Xiaoqin Feng
Chunfu Li
Mincui Zheng
Honggui Xu

Frontiers in Oncology

doi 10.3389/fonc.2021.712747

4,754 views
8 citations

Original Research

Published on 10 Sep 2021

Treosulfan-Based Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation: Long-Term Results From a Phase 2 Clinical Trial

in Hematologic Malignancies

Lorenzo Lazzari
Annalisa Ruggeri
Maria Teresa Lupo Stanghellini
Sara Mastaglio
Carlo Messina
Fabio Giglio
Alessandro Lorusso
Tommaso Perini
Simona Piemontese
Magda Marcatti

Frontiers in Oncology

doi 10.3389/fonc.2021.731478

9,362 views
13 citations

Systematic Review

Published on 09 Sep 2021

The Addition of Sirolimus to GVHD Prophylaxis After Allogeneic Hematopoietic Stem Cell Transplantation: A Meta-Analysis of Efficacy and Safety

in Hematologic Malignancies

Xiaoli Chen
Hengrui Sun
Kaniel Cassady
Shijie Yang
Ting Chen
Li Wang
Hongju Yan
Xi Zhang
Yimei Feng

Frontiers in Oncology

doi 10.3389/fonc.2021.683263

6,895 views
19 citations

Case Report

Published on 09 Sep 2021

Case Report: Contrasting BCL2 Upregulation With Venetoclax in a Case of Refractory Lymphomatoid Papulosis and Progressive Chronic Lymphocytic Leukemia

in Hematologic Malignancies

Valerio Guarente
Giovanni Martino
Erica Dorillo
Filomena De Falco
Chiara Rompietti
Daniele Sorcini
Mariangela Brogna
Valeria Cardinali
Stefano Ascani
Andrea Marra

Frontiers in Oncology

doi 10.3389/fonc.2021.729106

3,452 views
2 citations

Opinion

Published on 08 Sep 2021

Debating Frontline Therapy in Chronic Myeloid Leukemia

in Hematologic Malignancies

Xia Bi
Sabarina Ramanathan
Gina Keiffer

Frontiers in Oncology

doi 10.3389/fonc.2021.708823

3,961 views
2 citations

Original Research

Published on 07 Sep 2021

Molecular Heterogeneity in Localized Diffuse Large B-Cell Lymphoma

in Hematologic Malignancies

Wei Qin
Di Fu
Qing Shi
Lei Dong
Hongmei Yi
Hengye Huang
Xufeng Jiang
Qi Song
Zhenhua Liu
Shu Cheng

Frontiers in Oncology

doi 10.3389/fonc.2021.638757

5,172 views
11 citations

Original Research

Published on 06 Sep 2021

Downregulation of GNA15 Inhibits Cell Proliferation via P38 MAPK Pathway and Correlates with Prognosis of Adult Acute Myeloid Leukemia With Normal Karyotype

in Hematologic Malignancies

Mengya Li
Yu Liu
Yajun Liu
Lu Yang
Yan Xu
Weiqiong Wang
Zhongxing Jiang
Yanfang Liu
Shujuan Wang
Chong Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.724435

5,169 views
12 citations

Brief Research Report

Published on 06 Sep 2021

Immunological Response Against SARS-COV-2 After BNT162b2 Vaccine Administration Is Impaired in Allogeneic but Not in Autologous Stem Cell Transplant Recipients

in Hematologic Malignancies

Martina Chiarucci
Sara Paolasini
Alessandro Isidori
Barbara Guiducci
Federica Loscocco
Maria Capalbo
Giuseppe Visani

Frontiers in Oncology

doi 10.3389/fonc.2021.737300

4,693 views
35 citations

Original Research

Published on 06 Sep 2021

Letermovir Prophylaxis for Cytomegalovirus Infection in Allogeneic Stem Cell Transplantation: A Real-World Experience

in Hematologic Malignancies

Massimo Martino
Annalisa Pitino
Mercedes Gori
Benedetto Bruno
Alessandra Crescimanno
Vincenzo Federico
Alessandra Picardi
Stefania Tringali
Claudia Ingrosso
Paola Carluccio

Frontiers in Oncology

doi 10.3389/fonc.2021.740079

8,344 views
33 citations

Clinical Trial

Published on 03 Sep 2021

A Phase II Trial of the Double Epigenetic Priming Regimen Including Chidamide and Decitabine for Relapsed/Refractory Acute Myeloid Leukemia

in Hematologic Malignancies

Jia Yin
Chao-Ling Wan
Ling Zhang
Hao Zhang
Lian Bai
Hai-Xia Zhou
Ming-Zhu Xu
Li-Yun Chen
Chong-Sheng Qian
Hui-Ying Qiu

Frontiers in Oncology

doi 10.3389/fonc.2021.726926

4,618 views
7 citations

Original Research

Published on 02 Sep 2021

Metabolic Switch and Cytotoxic Effect of Metformin on Burkitt Lymphoma

in Hematologic Malignancies

Irene Bagaloni
Axel Visani
Sara Biagiotti
Annamaria Ruzzo
Mohsen Navari
Maryam Etebari
Lucia Mundo
Massimo Granai
Stefano Lazzi
Alessandro Isidori

Frontiers in Oncology

doi 10.3389/fonc.2021.661102

5,039 views
9 citations

Case Report

Published on 02 Sep 2021

Non-Hodgkin’s Lymphoma Presenting as Isolated Peritoneal Lymphomatosis: A Case Report and Literature Review

in Hematologic Malignancies

Min Zhu
Zhixuan Wu
Zhaoxia Yang
Bo Ning
Shengjie Yu
Xiling Gu
Huihong Yu

Frontiers in Oncology

doi 10.3389/fonc.2021.719554

8,810 views
6 citations

Review

Published on 01 Sep 2021

Roles of Histone Deacetylases in Acute Myeloid Leukemia With Fusion Proteins

in Hematologic Malignancies

Juan Zhang
Xuefeng Gao
Li Yu

Frontiers in Oncology

doi 10.3389/fonc.2021.741746

9,173 views
36 citations

Brief Research Report

Published on 31 Aug 2021

Enrichment of Double RUNX1 Mutations in Acute Leukemias of Ambiguous Lineage

in Hematologic Malignancies

Gabriele Merati
Marianna Rossi
Anna Gallì
Elisa Roncoroni
Silvia Zibellini
Ettore Rizzo
Daniela Pietra
Cristina Picone
Barbara Rocca
Claudia Patricia Tobar Cabrera

Frontiers in Oncology

doi 10.3389/fonc.2021.726637

3,753 views
6 citations

2,059 articles

articles

Case Report: Ocular Manifestations and Treatments of Ciliary Body Involvement by Lymphoma

Bortezomib Inhibits Multiple Myeloma Cells by Transactivating ATF3 to Trigger miR-135a-5p- Dependent Apoptosis

Case Report: Multi-Omics Analysis and CAR-T Treatment of a Chronic Myeloid Leukemia Blast Crisis Case 5 Years After the Discontinuation of TKI

Inefficacy of Immunosuppressive Therapy for Severe Aplastic Anemia Progressing From Non-SAA: Improved Outcome After Allogeneic Hematopoietic Stem Cell Transplantation

Somatic Mutations in Oncogenes Are in Chronic Myeloid Leukemia Acquired De Novo via Deregulated Base-Excision Repair and Alternative Non-Homologous End Joining

Safety and Efficacy of Anti-CD19-Chimeric Antigen Receptor T Cell Combined With Programmed Cell Death 1 Inhibitor Therapy in a Patient With Refractory Post-Transplant Lymphoproliferative Disease: Case Report and Literature Review

Salvage Therapy With Polatuzumab Vedotin, Bendamustine, and Rituximab Prior to Allogeneic Hematopoietic Transplantation in Patients With Aggressive Lymphomas Relapsing After Therapy With Chimeric Antigen Receptor T-Cells—Report on Two Cases

Editorial: Novel Treatment Strategies for Myeloproliferative Neoplasms

Comprehensive Clinicopathologic and Molecular Analysis of Mast Cell Leukemia With Associated Hematologic Neoplasm: A Report and In-Depth Study of 5 Cases

Four and a Half LIM Domains Protein 2 Mediates Bortezomib-Induced Osteogenic Differentiation of Mesenchymal Stem Cells in Multiple Myeloma Through p53 Signaling and β-Catenin Nuclear Enrichment

High EVI1 Expression Predicts Adverse Outcomes in Children With De Novo Acute Myeloid Leukemia

Treosulfan-Based Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation: Long-Term Results From a Phase 2 Clinical Trial

The Addition of Sirolimus to GVHD Prophylaxis After Allogeneic Hematopoietic Stem Cell Transplantation: A Meta-Analysis of Efficacy and Safety

Case Report: Contrasting BCL2 Upregulation With Venetoclax in a Case of Refractory Lymphomatoid Papulosis and Progressive Chronic Lymphocytic Leukemia

Debating Frontline Therapy in Chronic Myeloid Leukemia

Molecular Heterogeneity in Localized Diffuse Large B-Cell Lymphoma

Downregulation of GNA15 Inhibits Cell Proliferation via P38 MAPK Pathway and Correlates with Prognosis of Adult Acute Myeloid Leukemia With Normal Karyotype

Immunological Response Against SARS-COV-2 After BNT162b2 Vaccine Administration Is Impaired in Allogeneic but Not in Autologous Stem Cell Transplant Recipients

Letermovir Prophylaxis for Cytomegalovirus Infection in Allogeneic Stem Cell Transplantation: A Real-World Experience

A Phase II Trial of the Double Epigenetic Priming Regimen Including Chidamide and Decitabine for Relapsed/Refractory Acute Myeloid Leukemia

Metabolic Switch and Cytotoxic Effect of Metformin on Burkitt Lymphoma

Non-Hodgkin’s Lymphoma Presenting as Isolated Peritoneal Lymphomatosis: A Case Report and Literature Review

Roles of Histone Deacetylases in Acute Myeloid Leukemia With Fusion Proteins

Enrichment of Double RUNX1 Mutations in Acute Leukemias of Ambiguous Lineage